CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant

Authors:

Abstract
No abstract available

This publication has 49 references indexed in Scilit: